Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

322 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Frequency, entity and determinants of fatigue in Charcot-Marie-Tooth disease.
Bellofatto M, Bertini A, Tramacere I, Manganelli F, Fabrizi GM, Schenone A, Santoro L, Cavallaro T, Grandis M, Previtali SC, Falzone Y, Allegri I, Padua L, Pazzaglia C, Calabrese D, Saveri P, Quattrone A, Valentino P, Tozza S, Gentile L, Russo M, Mazzeo A, Vita G, Piacentini S, Pisciotta C, Pareyson D; Italian CMT Network. Bellofatto M, et al. Among authors: pareyson d. Eur J Neurol. 2023 Mar;30(3):710-718. doi: 10.1111/ene.15643. Epub 2022 Dec 2. Eur J Neurol. 2023. PMID: 36458502 Free PMC article.
Charcot-Marie-Tooth (CMT) 1a duplication at 17p11.2 in Italian families.
Bellone E, Mandich P, Mancardi GL, Schenone A, Uccelli A, Abbruzzese M, Sghirlanzoni A, Pareyson D, Ajmar F. Bellone E, et al. Among authors: pareyson d. J Med Genet. 1992 Jul;29(7):492-3. J Med Genet. 1992. PMID: 1640430 Free PMC article. No abstract available.
The POEMS syndrome: report of six cases.
Pareyson D, Marazzi R, Confalonieri P, Mancardi GL, Schenone A, Sghirlanzoni A. Pareyson D, et al. Ital J Neurol Sci. 1994 Oct;15(7):353-8. doi: 10.1007/BF02339932. Ital J Neurol Sci. 1994. PMID: 7698893
A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): the study protocol [EudraCT no.: 2006-000032-27].
Pareyson D, Schenone A, Fabrizi GM, Santoro L, Padua L, Quattrone A, Vita G, Gemignani F, Visioli F, Solari A; CMT-TRIAAL Group. Pareyson D, et al. Pharmacol Res. 2006 Dec;54(6):436-41. doi: 10.1016/j.phrs.2006.09.001. Epub 2006 Sep 9. Pharmacol Res. 2006. PMID: 17029975 Clinical Trial.
Reliability of clinical outcome measures in Charcot-Marie-Tooth disease.
Solari A, Laurà M, Salsano E, Radice D, Pareyson D; CMT-TRIAAL Study Group. Solari A, et al. Among authors: pareyson d. Neuromuscul Disord. 2008 Jan;18(1):19-26. doi: 10.1016/j.nmd.2007.09.006. Epub 2007 Oct 26. Neuromuscul Disord. 2008. PMID: 17964785 Clinical Trial.
Natural history of CMT1A including QoL: a 2-year prospective study.
Padua L, Pareyson D, Aprile I, Cavallaro T, Quattrone A, Rizzuto N, Vita G, Tonali P, Schenone A. Padua L, et al. Among authors: pareyson d. Neuromuscul Disord. 2008 Mar;18(3):199-203. doi: 10.1016/j.nmd.2007.11.008. Epub 2008 Jan 31. Neuromuscul Disord. 2008. PMID: 18242090
322 results